Previous work has suggested that ZEB1 and ZEB2 [16,17] as well as SNAI1 may play roles in AML transformation, and we have recently shown that Snai1 deletion can enhance survival in MLL-AF9 as well as AML-ETO/N-RAS AML models in vivo [60]. This evidence concerns the gene KMT2A and acute myeloid leukemia.